Health and Life Sciences Funding Round-Up
Posted on 04/06/2019
To make it easier to navigate the funding landscape KTN have pulled together the latest open relevant funding calls for the health sector into one place. Find out more details about each below; if you wish to find out more about further funding opportunities, please don’t hesitate to get in touch with our Health team.
Knowledge Transfer Partnerships
Current KTP period opened on 5th March, and closes on 6th May 2020 (after this the next round will be available immediately, so don’t rush your application unnecessarily).
A Knowledge Transfer Partnership (KTP) links your organisation with one of the UK’s world-class knowledge bases (a university or research organisation) to power strategic innovation projects, embed expertise and drive commercial growth. needed to develop it, a Knowledge Transfer Partnership may be the answer. It creates a dynamic three-way collaboration – between a business or not for profit organisation, a UK university or research organisation, and a suitably qualified graduate – to help realise a strategic innovation project, bring about transformative change and embed new capability.
Management Knowledge Transfer Partnerships
Just like our highly effective KTP programme, Management KTPs (MKTPs) create a dynamic 3-way partnership between your company, a team of academic experts and a skilled graduate. The focus of a MKTP is specifically on increasing effectiveness and improving results through better management practices.
The first round of these has now closed – visit ktp-uk.org to be kept informed about future MKTPs.
Innovate UK Smart Grants
Competition Closes: 22.04.20 (next round opens immediately after)
Smart is the new name for Innovate UK’s ‘Open grant funding’ programme. Innovate UK, as part of UK Research and Innovation, will invest up to £20 million in the best game-changing or disruptive ideas with a view to commercialisation. All proposals must be business focused, rather than pure research. Applications can come from any area of technology (including arts, design, media or creative industries), science or engineering and be applied to any part of the economy.
Proof of Concept funding call with Versus Arthritis
Versus Arthritis and the IKC are offering proof of concept funding to progress research ideas with commercial potential.The Proof of Concept Awards provide support and up to £100,000 to accelerate exciting innovations that help the lives of people with musculoskeletal conditions.Proposals are accepted from scientists, clinicians and allied health care professionals at eligible UK institutions, and collaborations with industry are encouraged.Applications will be judged on the clinical need, potential market opportunity and industry confidence to progress the technology to market.
RISPRO International Collaboration Call
Competition closes: 30th May 2020
The Managing Agency of the Endowment Fund for Education (recently known as LPDP) has recently launched the RISPRO International Collaboration (RISPRO-KI). The objective of the scheme is mainly to accelerate the national invention through international research collaboration. The transformation of collaboration outcome from “Co-authorship to Co-invention” becomes a target of this scheme.
The Indonesian Science Fund (known as DIPI) has recently been appointed as RISPRO’s delivery partner who has been responsible for the RISPRO-KI grant management which is a call for the proposal process, selection process, monitoring and evaluation. Based on this assignment, DIPI together with LPDP launched the 2020 RISPRO International Collaboration Call.
The call aims to provide grants for research in the following focus areas:
- Advance material or nanotechnology, and
Innovation Scholars Secondments
UKRI invites applications for individuals from any discipline wishing to spend up to 36 months (full or part time) on secondment in the biomedical sciences sector.
Proposals can come from any discipline but either the seconding or host organisation must be a business within the biomedical sciences sector (such as pharmaceutical, biotech, devices, biomedical engineering or diagnostics).
The objectives of the call are to:
- create porosity between sectors by enabling career mobility
- boost the skills, knowledge and career development of people
- intensify knowledge exchange between the biomedical industry and academia
- add value to the Biomedical Sciences sector and the UK economy by increasing productivity
This people-focused competition will achieve its objectives by supporting secondments to fund any activity that enhances the skills of, or provides career development for, the secondee and benefits the organisations involved. The secondee must work on an activity that works towards solving challenges within the secondment (host) environment.
There are 3 identical streams which open on the same date but have different close dates:
Bill & Melinda Gates Foundation, Wellcome & Mastercard COVID-19 Therapeutics Accelerator
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard have committed up to $125 million in seed funding to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term. Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on COVID-19.
IMI2 – Call 21: Development of therapeutics and diagnostics combatting coronavirus infections
Scope: Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:
- development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
- development of therapeutics to address the current and/or future coronavirus outbreaks;
- development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
- development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.
Preventive vaccines are specifically excluded from the scope of the Call.
Deadline: 17.00 on Wednesday 18th March
The European Commission is calling for startups and SMEs with technologies and innovations that could help in treating, testing, monitoring or other aspects of the Coronavirus outbreak to apply urgently to the next round of funding from the European Innovation Council. With a budget of €164m, this call is “bottom up”, meaning there are no predefined thematic priorities and applicants with Coronavirus relevant innovations will be evaluated in the same way as other applicants. Nevertheless, the Commission will look to fast track the awarding of EIC grants and blended finance (combining grant and equity investment) to Coronavirus relevant innovations, as well as to facilitate access to other funding and investment sources.
NIHR: Artificial Intelligence Health and Care Award
The Artificial Intelligence Health and Care Award supports solutions addressing the strategic aims of the NHS Long Term Plan across the whole development pathway, from initial feasibility to clinical implementation. The Artificial Intelligence (AI) Health and Care Award is run in partnership with the Accelerated Access Collaborative and NHSX. It is part of the NHS Artificial Intelligence Lab announced by the Health Secretary in 2019, and will deploy £140m over three years to accelerate the testing and evaluation of the most promising AI technologies that meet the strategic aims set out in the NHS Long Term Plan. The award will support AI technologies across the spectrum of development, from initial feasibility to evaluation within clinical pathways in the NHS and social care settings, to the point that they could be nationally commissioned. Key areas of focus include screening, diagnosis, decision support and system efficiency.
Bucks HSC Ventures: 2020 Cohort Three
Bucks HSC Ventures has developed a clear programme path that puts the SME and their idea at the heart of all analysis and development. The Bucks HSC Ventures programme is offered by the Bucks Health and Social Care Innovation Hub project which is part funded by the European Regional Development Fund (ERDF) as part of the European Structural and Investment Funds Growth Programme 2014-2020.
Funding for Medical Technology Trials in Leicester and Leicestershire
Funds available until December 2021.
Med-Tech Trial grants of up to £50,000 are available for eligible life science companies in Leicester and Leicestershire, to test and evaluate their products and services in a clinical setting. This ensures that they are working as intended, are effective and are safe for use. The gathering of this evidence is vital for companies wanting to sell their products and services to the healthcare market – including the NHS.
SIGHT is a business support programme developed by the University of Portsmouth to provide help and guidance to small and medium-sized businesses (SMEs) in the healthcare technology sector.
The programme aims to enhance the competitiveness of businesses in the healthcare sector in the south east region by working collaboratively with industry partners, patient groups, clinicians and academics to provide quicker access to groundbreaking healthcare technologies. The £1.7m programme is part-funded by the ERDF (European Regional Development Fund) and will draw on clinical and academic expertise from the University and from our delivery partners, Portsmouth Hospitals NHS Trust and the Clinical Research Network Wessex.
SIGHT will support businesses to engage through the Portsmouth Technologies Trials Unit (PTTU) – a joint initiative between Portsmouth Hospitals NHS Trust and the University of Portsmouth which provides specialist expertise in healthcare technologies. The programme will also help companies to become more aware of the challenges they could face bringing products to market in this sector – and help them find ways to successfully overcome them.
STFC Bridging for Innovators (B4I) programme
The Science and Technology Facilities Council (STFC) is a multidisciplinary research organisation that funds and operates a number of large science facilities offering research and development access to commercial users. Through these facilities, and their expert staff, they can provide access to advanced experimental and computational tools to address challenges in all aspects of the chemicals supply chain. Their £8 million Bridging for Innovators (B4I) programme is specifically designed to help companies overcome difficult product, manufacturing or process performance issues by providing access to advanced analytical technologies, supporting expertise and capabilities through STFC’s large scale science facilities located around the UK. The program runs until April 2021.
Healthcare Technologies: Call for Investigator-led Research Projects
The EPSRC Healthcare Technologies theme has prioritised funding to support novel investigator-led projects. They would particularly like to encourage research projects which address the priorities of “Transform community health and care” and “Improve prevention and public health”. This funding is currently paused (as of May 2019), but you can sign up to their newsletter to be informed when it reopens.
The ICURe Innovation to Commercialisation programme offers university researchers with commercially-promising ideas up to £35k to ‘get out of the lab’ and validate their ideas in the marketplace. Up to £35k of funding from InnovateUK is available over the three months for each team, this includes a salary for the Early Career Researcher (ECR) and a travel budget for the ECR. ICURe starts with an intense 3 Day Training Bootcamp where you become familiar with the Business Model Canvas, have time to think about your Value Proposition and propose a budget and action plan for your market validation discovery.
Creative England Investments
Creative England is supporting SMEs by providing competitive loans to digital businesses in order to make their growth plans a reality. The investments on offer are intended to fuel this fast-growing sector by financing business expansion and new products, leading to the creation of new high-quality jobs and Intellectual Property (IP). Loans from £50,000 – £250,000 are available with repayment terms ranging from 3-36 months. Interest rates range from 5% – 10%, depending on the risk profile of the applicant. This includes companies from within the digital healthcare sector.
BactiVac Network – Catalyst Training Awards
An open call for BactiVac catalyst funding training awards is now OPEN. Funding is available to support training opportunities and exchanges, prioritising those involving LMIC members and academic/industrial partners, for the transfer of knowledge and skills in bacterial vaccinology. Up to £6,000 per award is available and each training visit is expected to be up to three months in duration. The aim of this funding scheme is to support members to train in vaccine research & development (R&D), targeting the main preclinical to clinical area of focus for BactiVac. The call for applications is an open call, you can apply at any time.
Global Health Innovative Technology Fund
The GHIT Fund facilities and invests in global partnerships for the discovery and development of new health technologies, including drugs, vaccines and diagnostics, for infectious diseases prevalent in developing countries.
NIHR Research for Social Care
Most recent call closed January 2020: check the website for details of the 2021 call.
The RfSC call is an annual competition for social care research proposals, which will be assessed by a national committee of social care research experts. The budget for this call will be £3m, and individual projects will be funded up to £350k.
NIHR Invention for Innovation
The aim of the Invention for Innovation (i4i) programme is to de-risk early stage projects that have a strong potential for commercialisation and acceptance for use in the NHS, making them attractive to follow-on funders and investors.
i4i funds collaborative research projects that have demonstrated proof-of-principle and have a clear pathway towards adoption and commercialisation.
Horizon 2020 Calls
Horizon 2020 is the EU’s €77 billion research and innovation funding scheme running from 2014 to 2020. The Department for Business Energy and Industrial Strategy (BEIS) has published a document providing an overview of the UK’s relationship with Horizon 2020. This is followed by a Q&A, which clarifies the UK’s eligibility to participate in Horizon 2020. Current calls of particular relevance to Health include:
- DT-ICT-12-2020: AI for the smart hospital of the future. Competition opens 19 November 2019 and closes 22 April 2020.
- SC1-DTH-02-2020: Personalised early risk prediction, prevention and intervention based on Artificial Intelligence and Big Data technologies. Competition opens 19 November 2019 and closes 22 April 2020.
- SC1-DTH-04-2020: International cooperation in smart living environments for ageing people. Competition opens 19 November 2019 and closes 22 April 2020.
- DT-TDS-04-2020: AI for Genomics and Personalised Medicine. Competition opens 19 November 2019 and closes 22 April 2020.
- DT-TDS-05-2020: AI for Health Imaging. Competition opened 9 July 2019 and closes 13 November 2020.